INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -46.4% | 26,504 | +5.9% | 0.00% | – |
| Q4 2021 | $56,000 | -54.1% | 25,017 | -29.9% | 0.00% | – |
| Q3 2021 | $122,000 | +19.6% | 35,706 | +4.8% | 0.00% | – |
| Q2 2021 | $102,000 | -30.6% | 34,064 | +153.0% | 0.00% | – |
| Q2 2015 | $147,000 | -27.2% | 13,465 | -15.1% | 0.00% | – |
| Q2 2014 | $202,000 | -12.9% | 15,861 | +19.2% | 0.00% | – |
| Q3 2013 | $232,000 | -10.1% | 13,305 | -16.3% | 0.00% | -100.0% |
| Q2 2013 | $258,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |